Clinical Trials Directory

Trials / Completed

CompletedNCT03209804

Surgical Management of Cerebral Arteriovenous Malformations Within Hybrid Operation Room

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
519 (actual)
Sponsor
Ministry of Science and Technology of the People´s Republic of China · Other Government
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

To evaluate the clinical benefits and risks of hybrid operating techniques in management of cerebral arteriovenous malformations.

Detailed description

Purpose: Have an evaluation of clinical benefits and risks of hybrid operating techniques in management of cerebral arteriovenous malformations(AVMs). Meanwhile, as a new cooperative interventional modality, optimized workflows, technical key knots and operation routines will be explored in the study. Objects: Patients with cerebral arteriovenous malformations, coincident with inclusion and exclusion criterion and admitted in participating organizations. Methods: Patients will be distributed into 2 groups, including traditional therapy group(control group) and hybrid operating group(trial group), and conduct with traditional neurosurgical management or one-stage hybrid operating management correspondingly. Residual rate of AVM is considered to be the primary observing indicator, and morbidity rate of post-operative complications, post-operative mortality rate, and morbidity rate of neural functional deterioration are secondary indicators.The information of operations will be recorded in detail as evidence of optimization of workflow and technical key knots.

Conditions

Interventions

TypeNameDescription
PROCEDUREhybrid operating techniquesA one-stage cooperation of existing endovascular interventional techniques and microsurgical techniques, including microsurgical resection, endovascular embolization, balloon occlusion.

Timeline

Start date
2016-06-01
Primary completion
2019-12-01
Completion
2020-01-16
First posted
2017-07-06
Last updated
2020-03-13

Locations

4 sites across 1 country: China

Source: ClinicalTrials.gov record NCT03209804. Inclusion in this directory is not an endorsement.